Article Text
Statistics from Altmetric.com
Summary box
Available evidence indicates that children and adolescents can transmit SARS-CoV-2 infection and are also vulnerable to severe disease and death.
There has been recent acceleration in approvals, initiation and scale-up of COVID-19 vaccination among children under 18 years in high-, low- and middle-income countries around the world.
Current data indicate that children in African countries also experience COVID-19-related morbidity and mortality, which may be worse than that of their counterparts in other regions of the world.
In this article, we outline the global status quo on scale-up of safe and effective COVID-19 vaccines for younger populations, and make an argument for why African children and adolescents should also be targeted for vaccination.
Introduction
Since the onset of the COVID-19 pandemic in December 2019, scientists have worked expediently to develop effective treatments and vaccines for clinical management and prevention of COVID-19. Drugs such as remdesivir, dexamethasone and, more recently, molnupiravir have had modest to impressive results in reducing risk of hospital admission, time to discharge, morbidity and/or mortality.1–3
COVID-19 vaccine development and evaluation in clinical trials has been rapid, with safe, effective vaccines being available within 12 months into the pandemic. There are several RNA, DNA, viral vector, inactivated and protein subunit COVID-19 vaccines approved for use.4 Table 1 shows the most widely used approved vaccines across each vaccine type.5 None of these vaccines are currently manufactured in any African country; however, participants in a few African countries have been enrolled in adult and, more recently, paediatric trials for these vaccines.4 6 7 Global, equitable access to safe and effective vaccines for all age groups is critical to ending the COVID-19 pandemic.
- In this window
- In a new window
- In this window
- In a new window
Global COVID-19 vaccine approvals for children and adolescents
There is …